Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE MATIP : revenue, balance sheet and financial ratios

SELARL PHARMACIE MATIP is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in EVRY-COURCOURONNES (91000), this company of category PME shows in 2024 a net income positive of 67 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE MATIP (SIREN 907467385)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income 67 358 € 159 356 € 184 478 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE MATIP generates positive net income of 67 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2024: 184 k€ -> 67 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

67 358 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 126%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

125.819%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

34.58%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

81.8%

Solvency indicators evolution
SELARL PHARMACIE MATIP

Sector positioning

Debt ratio
125.82 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average -8 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE MATIP (125.82) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
34.58% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +7 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE MATIP (34.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 282.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

282.68

Liquidity indicators evolution
SELARL PHARMACIE MATIP

Sector positioning

Liquidity ratio
282.68 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent +37 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE MATIP (282.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE MATIP in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE MATIP is estimated at 940 367 € (range 654 857€ - 1 406 843€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
654k€ 940k€ 1406k€
940 367 € Range: 654 857€ - 1 406 843€
NAF 5 année 2024

Valuation method used

Net Income Multiple
67 358 € × 14.0x = 940 367 €
Range: 654 857€ - 1 406 844€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE MATIP with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE MATIP

What is the revenue of SELARL PHARMACIE MATIP ?

The revenue of SELARL PHARMACIE MATIP is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE MATIP profitable?

Yes, SELARL PHARMACIE MATIP generated a net profit of 67 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE MATIP ?

The headquarters of SELARL PHARMACIE MATIP is located in EVRY-COURCOURONNES (91000), in the department Essonne.

Where to find the tax return of SELARL PHARMACIE MATIP ?

The tax return of SELARL PHARMACIE MATIP is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE MATIP operate?

SELARL PHARMACIE MATIP operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.